Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 400 shares traded hands during mid-day trading, a decline of 8% from the previous session’s volume of 433 shares.The stock last traded at $17.12 and had previously closed at $16.60.
Analyst Ratings Changes
Separately, Jefferies Financial Group raised Demant A/S from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy”.
Read Our Latest Research Report on WILYY
Demant A/S Stock Performance
Demant A/S Company Profile
Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.
Read More
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
